Procurement Summary
Country: USA
Summary: Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures Sap Purchase Order for Supply Chain Monitoring Infant Formula
Deadline: 10 Jul 2026
Posting Date: 08 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144714255
Document Ref. No.: HFP-2026-134162
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial service contract to Circana, LLC (Circana), 203 North LaSalle Street, Suite 1500, Chicago, IL, 60601, USA, for the Purchase of Supply Chain Monitoring - Infant Formula in accordance with the authority under FAR RFO Part 6.103-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Circana is the only known source capable of obtain critical data needed to monitor the availability of infant formula products in the United States to support continuity of the FDA-s monitoring the infant formula supply chain - U.S. infant formula shortage initiative. No other sources have expressed an interest in writing in the proposed acquisition.
This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.
The North American Industry Classification System (NAICS) code for the proposed acquisition is 541910 - Marketing Research and Public Opinion Polling $22.5.
Deliverables:
CLIN 1 - Out of Stock Tracking Solution (OOS) - 2 user licenses - Estimated Delivery Date 07/30/2026 (Valid 1 Year)
CLIN 2 - Liquid Data Go (LDG) - 1 user license - Estimated Delivery Date 07/30/2026 (Valid 1 Year)
Responses
Responses to this notice should be sent to Haroon Gulzar at [email protected] no later than 5:00 pm (ET) on July 10, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
Notice ID: hfp-2026-134162
Department/Ind. Agency: health and human services, department of
Sub-tier: food and drug administration
Office: fda office of acq grant svcs
Product Service Code: b506 - special studies/analysis- data (other than scientific)
NAICS Code: 541910 - Marketing Research and Public Opinion Polling
Inactive Dates: jul 25, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice